Wealthcare Advisory Partners LLC Teva Pharmaceutical Industries LTD Transaction History

Wealthcare Advisory Partners LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $49,163 - $57,406	-4,966 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$10.34 - $12.81 $51,348 - $63,614	4,966 New	4,966 $57,000
Q2 2020 Jul 29, 2020	SELL	$8.12 - $13.12 $10,085 - $16,295	-1,242 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$6.69 - $13.45 $7,526 - $15,131	1,125 Added 961.54%	1,242 $11,000
Q4 2019 Jan 29, 2020	SELL	$6.53 - $10.72 $1,201 - $1,972	-184 Reduced 61.13%	117 $1,000
Q3 2019 Oct 17, 2019	SELL	$6.16 - $9.6 $308 - $480	-50 Reduced 14.25%	301 $2,000
Q2 2019 Jul 30, 2019	SELL	$8.12 - $15.72 $405 - $786	-50 Reduced 12.47%	351 $3,000
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $729 - $1,192	50 Added 14.25%	401 $6,000
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $77,443 - $114,110	-4,618 Reduced 92.94%	351 $9,000
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $834 - $1,103	50 Added 1.02%	4,969 $85,000
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $38,193 - $64,959	3,401 Added 224.04%	4,919 $93,000
Q3 2017 Nov 15, 2017	BUY	$15.41 - $32.17 $23,392 - $48,834	1,518	1,518 $27,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.